Imatics declares $110 million underwriting providing of extraordinary shares hAustin, Texas And T├╝bingenGermany, october 10, 2022 – Emetics N.V. (NASDAQ: IMTX, “Imetics”), a clinical-stage biopharmaceutical firm energetic within the discovery and improvement of T cell-redirecting most cancers immunotherapies, right now introduced that it’ll promote by an underwritten public providing. has agreed to 10,905,000 of its frequent shares at a value of $10,905,000 per … Read more